CD9 and multiple sclerosis: Modulation of CD9 expression is even under consideration in auto-immune diseases, such as multiple sclerosis (74), in which blocking CD9 in vitro strongly enhances the blood-brain barrier function and reduces the migration of monocytes across brain endothelial cell monolayers.